127 views
0

WHY THIS MATTERS IN BRIEF

Being able to detect fatal heart conditions before they kill you is a good thing… enough said.

 

The most common type of Arrhythmia, a form of atrial fibrillation, is an irregular beating of the heart that can lead to stroke, blood clots, or heart failure if left unchecked, and it’s often deadly. Furthermore, unless you’re using an electrocardiogram it can be very difficult to detect but soon all that could change and all you’ll need to detect one of the world’s deadliest heart conditions is a smartphone app.

 

RELATED
Breakthrough genetic treatment slows the progression of Huntingdons Disease

 

Back in 2011 scientists from the University of Turku in Finland collaborated with colleagues at Turku University Hospital to see if small accelerometers could be used to detect the tell tale tiny chest movements associated with Arrhythmia and it turned out that they could. In turn this then got them wondering if they could use the tiny accelerometers in a standard smartphone to detect the condition.

Now, six years on from that early research, the team, which is led by researcher Tero Koivisto, have created an app that requires the smartphone to simply be placed upon the patient’s chest, where it detects and analyses the micromovements caused by their heartbeat in order to detect the condition.

In a blind study conducted on 300 patients from the hospital, half of whom had Arrhythmia, the app was 96 percent accurate at detecting the condition, and even more impressively it was able to do it even though many of the patients also had other pre-existing heart conditions.

 

RELATED
DARPA's new P3 program aims to stop all pandemics dead within 60 days

 

The app is now being developed further and it’s hoped it will soon be commercialised by a spinoff company called Precordior and, just like some of the other breakthroughs recently that are also helping democratise access to healthcare, such as ultrasound on a smartphone, and being able to use your voice to detect and diagnose disease, or your smartphone’s camera to diagnose dangerous cancers, the new technology will give patients around the world yet another powerful tool that they can use to check and monitor their own health with.

A paper on the research was recently published in the Circulation Journal.

Meanwhile elsewhere scientists from the Chinese University of Hong Kong have also developed an atrial fibrillation detection app, but rather than detecting micromovements it uses the smartphone’s camera to analyse subtle change in the patients facial skin colour that are often another indicator of a fluctuating heart rate. Let the democratisation of healthcare continue!

About author

Matthew Griffin

Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the 311 Institute, a global futures and deep futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future.” Regularly featured in the global media, including AP, BBC, CNBC, Discovery, RT, and Viacom, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Bain & Co, BCG, BOA, Blackrock, Bentley, Credit Suisse, Dell EMC, Dentons, Deloitte, Du Pont, E&Y, GEMS, HPE, Huawei, JPMorgan Chase, KPMG, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, UBS, and many more.

Comments

Your email address will not be published. Required fields are marked *